In addition, molecules produced by PCa cells and inflammatory cells in the tumor microenvironment, such as PlGF, can recruit inflammatory/myeloid-derived cells and create an immunosuppressive environment that drives prostate carcinogenesis and prevents the development of an efficient immune response against PCa cells. This evidence concerns the gene PGF and neoplasm.